Healthcare and biotechnology have not faltered during recent weeks. No matter what announcements have come up regarding the potential trade war, stocks in this sector have continued to rally this summer. A number of mid and late stage biotech stocks have begun reporting pivotal research progress that could help bolster more attention in the market. … Continue reading 3 Biotech Stocks See Healthy Progress This Month →

What To Pay Attention To & Why Biotech Is The Industry To Watch Right Now Over the last 3 months, the Health Care Select Sector SPDR Fund (XLV) has been climbing back toward its 52 week high. Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) have maintain their … Continue reading Industry Report: Is Biotech Part Of Your Portfolio Yet? →

Both the SPDR S&P Biotech ETF (XBI) and the iShares NASDAQ Biotechnology Index ETF (IBB) extended gains on Thursday afternoon. Both funds have been in an uptrend for the better part of the last 3 days to begin the month of August. XBI + IBB Daily Chart As Of 8–3–2018 For a number of companies, earnings have taken … Continue reading 3 Biotech Stocks You Might Have Missed For Your August Watchlist →

The Nasdaq iShares Biotechnology Index (IBB) has taken a turn toward “greener pastures”. The ETF rose by more than 1.2% on Tuesday as a number of biotech stocks moved higher in early morning trading. Additionally, a number of other ETF’s tracking the healthcare and biotech sectors have reversed from bearish trends and are heading higher … Continue reading Thursday Industry Report: 3 Biotech Stocks In Focus On Thursday →